@madara_t1: #sasuke #sasukeuchiha #edit #narutoshippuden #anime #editingnews ・ Upload Method → @editingnews.com

Madara
Madara
Open In TikTok:
Region: JP
Thursday 17 September 2026 16:45:17 GMT
5835
741
14
67

Music

Download

Comments

alien.x.celestial
Alien X Celestialsapien :
trust me guys Sasuke Uchiha is still GOAT 🐐
2026-09-17 17:26:42
4
iamdxmnd
DXMND 💎 :
Yoo this edit is so fire 🔥 thanks for using our song intercept
2026-09-17 17:12:07
1
foysal76xi
@yr!Urfav*] :
the bsttttt editttt✨🫶
2026-09-17 17:12:57
1
boruto8707
BORUTO EDIT :
peak edit
2026-09-17 17:16:35
0
roughporan
Rough Poran :
Me in every Universe ✅
2026-09-17 16:56:53
2
muhamadhassan31
Mohammed Hassn :
SASUKE
2026-09-17 18:02:22
2
nickname.tt94
—͞ 𝗡 𝗜 𝗖 𝗞 𝗡 𝗔 𝗠 𝗘 :
1st
2026-09-17 16:51:21
1
doraemon7091
★𝗗𝗢𝗥𝗔𝗘𝗠𝗢𝗡★ :
frist
2026-09-17 16:52:05
0
ermelindasaldanh9
Shinobu2.0 :
edit peaK
2026-09-17 18:17:28
1
fypzfsstro
梅西 & 宇智波鼬 :
SASUKE 🔪🗿
2026-09-18 02:39:20
0
lalalaaaa_99
жырная бургерова ок :
2026-09-17 16:56:02
0
doraemon7091
★𝗗𝗢𝗥𝗔𝗘𝗠𝗢𝗡★ :
follow back plz
2026-09-17 16:52:15
0
nahidty00
TS.Ɲᴀʜɪᴅ...... :
[Innocent][Innocent][Innocent]
2026-09-17 16:54:59
0
mrbeastworldofficial
☘️ ฉันชื่ออีฟ ☘️ :
[Heartwarming]
2026-09-17 17:14:32
0
To see more videos from user @madara_t1, please go to the Tikwm homepage.

Other Videos

Big news in the world of Obesity Medicine and weight management today, and I want to make sure you actually understand what it means, not just that it happened. The FDA just approved Foundayo (orforglipron), Eli Lilly's once-daily GLP-1 pill for obesity, and it's worth paying attention to. Here's what you need to know: The clinical data: In the Phase 3 ATTAIN trials, patients lost an average of 12.4% of their body weight at the highest dose over 72 weeks. Real, meaningful weight loss. Less than Zepbound's ~21%, but this isn't a shot. It's a pill. The access piece: With commercial insurance, eligible patients could pay as little as $25/month. Self-pay starts at $149. Medicare Part D coverage could begin as early as July at $50/month. For a category where people have been paying $1,000+/month, that matters enormously. The practical difference: Unlike the Wegovy pill, which requires an empty stomach and a 30-minute wait, Foundayo can be taken any time, no food or water restrictions. Side effects: Same GI profile as the rest of this class. The thyroid cancer warning is there too, so if you have a history of medullary thyroid carcinoma, this isn't for you. Is it a replacement for the injectables? No. A legitimate option for people who want oral medication, or an oral maintenance strategy after hitting goal weight? Yes. I sat down one on one with Dave Ricks, CEO of Eli Lilly. That interview is coming, and I think it'll change how you think about where this whole category is headed. Stay close.   Note: I have not been compensated in any way for this post/interview.  #Foundayo #newGLP-1 #GLP-1pill #EliLilly
Big news in the world of Obesity Medicine and weight management today, and I want to make sure you actually understand what it means, not just that it happened. The FDA just approved Foundayo (orforglipron), Eli Lilly's once-daily GLP-1 pill for obesity, and it's worth paying attention to. Here's what you need to know: The clinical data: In the Phase 3 ATTAIN trials, patients lost an average of 12.4% of their body weight at the highest dose over 72 weeks. Real, meaningful weight loss. Less than Zepbound's ~21%, but this isn't a shot. It's a pill. The access piece: With commercial insurance, eligible patients could pay as little as $25/month. Self-pay starts at $149. Medicare Part D coverage could begin as early as July at $50/month. For a category where people have been paying $1,000+/month, that matters enormously. The practical difference: Unlike the Wegovy pill, which requires an empty stomach and a 30-minute wait, Foundayo can be taken any time, no food or water restrictions. Side effects: Same GI profile as the rest of this class. The thyroid cancer warning is there too, so if you have a history of medullary thyroid carcinoma, this isn't for you. Is it a replacement for the injectables? No. A legitimate option for people who want oral medication, or an oral maintenance strategy after hitting goal weight? Yes. I sat down one on one with Dave Ricks, CEO of Eli Lilly. That interview is coming, and I think it'll change how you think about where this whole category is headed. Stay close. Note: I have not been compensated in any way for this post/interview. #Foundayo #newGLP-1 #GLP-1pill #EliLilly

About